Machine Learning-Enabled Surface-Enhanced Raman Scattering for Label-Free Tracking of Hepatic Fibrosis Progression
ACS Sensors · 2026
DOI: 10.1021/acssensors.6c01175 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, 2026. Verfasst von Yayun Qian und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou225003, China. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Machine Learning, Liver Cirrhosis. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Jiangsu Commission of Health.
Abstract (Originalsprache)
Accurate monitoring of liver fibrosis (LF) is critical for the clinical management and prognostic evaluation of liver diseases. However, it remains challenging to develop a reliable and efficient method for tracking LF progression and identifying its etiological characteristics. Herein, we present an innovative strategy combining label-free surface-enhanced Raman scattering (SERS) technology and advanced machine learning (ML) for the etiological tracking and staging diagnosis of LF. Specifically, a highly sensitive, uniform Au cluster-structured nanoarray (AuCSNAs) substrate was fabricated via reactive ion etching (RIE) and gas–liquid interface self-assembly, obtaining high-quality serum SERS spectra from carbon tetrachloride (CCl4)-, dimethylnitrosamine (DMN)-, and thioacetamide (TAA)-induced LF mice at weeks 0, 3, and 6. Subsequently, the principal component analysis (PCA)-Meta-learning Random Forest-Lite (Meta-RF-Lite) model was constructed to extract, identify, and analyze these spectra. The PCA-Meta-RF-Lite model realized robust discrimination of SERS spectra from distinct LF etiologies and pathological stages, which can reach an accuracy of up to 98.3%, a sensitivity of up to 100.0%, a specificity of up to 98.7%, and an AUC of up to 0.989. Collectively, these results verify that the AuCSNAs/PCA-Meta-RF-Lite strategy enables reliable tracking and etiological differentiation of LF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Faculty of Medicine, Yangzhou University, Yangzhou225003, China.
- NATCM Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer, Faculty of Medicine, Yangzhou University, Yangzhou225003, China.
- Department of Infectious Diseases, Affiliated Huai'an Fifth People's Hospital, Yangzhou University, Huai'an223300, China.
- Department of Intensive Care Unit, Wuxi Huishan District People's Hospital, Huishan Clinical College, Medical College of Yangzhou University, Wuxi214187, China.
ORCID-Profile: Ruoyu Zhou, Wei Zhang
Förderung
- Jiangsu Commission of Health
Zitieren
APA
Qian, Y., Zhang, X., Zhai, X., Xie, Y., Li, T., Zhang, Z., Chen, L., Zhou, R., & Zhang, W. (2026). Machine Learning-Enabled Surface-Enhanced Raman Scattering for Label-Free Tracking of Hepatic Fibrosis Progression. ACS Sensors. https://doi.org/10.1021/acssensors.6c01175
Vancouver
Qian Y, Zhang X, Zhai X, Xie Y, Li T, Zhang Z, et al. Machine Learning-Enabled Surface-Enhanced Raman Scattering for Label-Free Tracking of Hepatic Fibrosis Progression. ACS Sensors. 2026. doi:10.1021/acssensors.6c01175
BibTeX
@article{Qian2026,
author = {Qian, Yayun and Zhang, Xudong and Zhai, Xuezhen and Xie, Yanting and Li, Tianran and Zhang, Zhaohan and Chen, Lepeng and Zhou, Ruoyu and Zhang, Wei},
title = {Machine Learning-Enabled Surface-Enhanced Raman Scattering for Label-Free Tracking of Hepatic Fibrosis Progression},
journal = {ACS Sensors},
year = {2026},
doi = {10.1021/acssensors.6c01175}
}
EUVIMED